Non-alcoholic fatty liver disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Case Group: 1. Aged 18 years or older; 2. Patients meeting surgical indications related to liver diseases (primary liver cancer, liver metastases, hepatic hemangioma, liver cysts, hepatobiliary stones, end-stage liver disease, etc.); 3. Patients diagnosed with non-alcoholic fatty liver disease (NAFLD). Control Group: 1. Aged 18 years or older; 2. Patients meeting surgical indications related to liver diseases (primary liver cancer, liver metastases, hepatic hemangioma, liver cysts, hepatobiliary stones, end-stage liver disease, etc.); 3. Patients without non-alcoholic fatty liver disease (NAFLD).
Exclusion criteria
Exclusion criteria: Case Group: 1. Patients with severe diseases of important organs such as the heart, lungs, kidneys, or brain, or other malignant tumors: these conditions may affect survival risk, thereby interfering with the accuracy of the model's predictions; 2. Pregnant or breastfeeding women: the physiological and pathological conditions during pregnancy and breastfeeding may be special, and for ethical considerations, such patients are usually excluded. Control Group: 1. Patients with severe diseases of important organs such as the heart, lungs, kidneys, or brain, or other malignant tumors: these conditions may affect survival risk, thereby interfering with the accuracy of the model's predictions; 2. Pregnant or breastfeeding women: the physiological and pathological conditions during pregnancy and breastfeeding may be special, and for ethical considerations, such patients are usually excluded; 3. Patients diagnosed with non-alcoholic fatty liver disease (NAFLD).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in liver fat content;Liver function indicators;Degree of hepatic inflammatory activity;GSTM3 expression level; | — |
Countries
China
Contacts
The Affiliated Hospital of Guangdong Medical University